Steven Sell - 01 Apr 2025 Form 4 Insider Report for agilon health, inc. (AGL)

Role
CEO & President, Director
Signature
/s/ Mimi Yang, as Attorney-in-Fact
Issuer symbol
AGL
Transactions as of
01 Apr 2025
Transactions value $
$0
Form type
4
Filing time
03 Apr 2025, 19:36:12 UTC
Previous filing
18 Mar 2025
Next filing
16 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGL Common Stock Award $0 +551,471 +1.55% $0 906,781 01 Apr 2025 Direct F1, F2
holding AGL Common Stock 67,590 01 Apr 2025 By trust F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGL Options (Right to buy) Award $0 +865,385 $0 865,385 01 Apr 2025 Common Stock 865,385 $4.08 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units that vest in three equal installments on each anniversary of April 1, 2025, subject to continued employment.
F2 Includes restricted stock units.
F3 These shares of common stock are held in the Steven J. Sell and Margaret D. Williams Revocable Inter Vivos Trust Agreement.
F4 Options that vest in three equal installments on each anniversary of April 1, 2025, subject to continued employment.